Main Street Financial Solutions’s Pfizer PFE Stock Holding History

Main Street Financial Solutions’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,000	Closed	-$180	–	625
2025 Q3	$180	Hold	4,000	–	–	﹤0.01%	608
2025 Q2	$180	Hold	4,000	–	–	﹤0.01%	553
2025 Q1	$580	Hold	4,000	–	–	﹤0.01%	510
2024 Q4	$1.38K	Hold	4,000	–	–	﹤0.01%	484
2024 Q3	$2.98K	Hold	4,000	–	–	﹤0.01%	530
2024 Q2	$3.66K	Buy	+4,000	New	+$110K	﹤0.01%	539

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Main Street Financial Solutions's PFE Position: Q2 2026 in Review

Main Street Financial Solutions increased its Pfizer (PFE) stake by 1.9% in Q2 2026, buying an estimated $16.1K and bringing the position to 33,453 shares worth $806K. The position accounts for 0.05% of the portfolio, ranked #283.

Main Street Financial Solutions first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.54M in Q2 2022. 2,841 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

Main Street Financial Solutions held 33,453 shares of Pfizer worth $806K as of Q2 2026.
Main Street Financial Solutions bought 617 Pfizer shares in Q2 2026, an estimated $16.1K.
Pfizer made up 0.05% of Main Street Financial Solutions's portfolio in Q2 2026, its #283 holding.
Main Street Financial Solutions first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
Main Street Financial Solutions's Pfizer position peaked at $1.54M in Q2 2022.
2,841 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Main Street Financial Solutions's 13F filing for Q2 2026, filed 7 Aug 2026.